MYC and cancer: Additionally, BRAFmut/MSS cancers had a higher frequency of targeted amplification of 8q24.13 that contains the Wnt signalling effector, Myc. These Wnt pathway related genes that may be specifically targeted in BRAFmut/MSS cancers could be an alternative mechanism in promotion of the Wnt signal in this cancer subtype.